|
Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors |
|
|
|
Title: |
Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors |
Author: |
Doi, Toshihiko Ohtsu, Atsushi Fuse, Nozomu Yoshino, Takayuki Tahara, Makoto Shibayama, Kazuhiro Takubo, Takatoshi Weinreich, David M. |
Appeared in: |
Cancer, chemotherapy and pharmacology |
Paging: |
Volume 71 (2012) nr. 1 pages 227-235 |
Year: |
2012 |
Contents: |
|
Publisher: |
Springer-Verlag, Berlin/Heidelberg |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|